SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-020299
Filing Date
2024-05-03
Accepted
2024-05-03 16:16:53
Documents
68
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q vir-20240331.htm   iXBRL 10-Q 1133115
2 EX-31.1 a20240503-q110qex311.htm EX-31.1 10761
3 EX-31.2 a20240503-q110qex312.htm EX-31.2 10723
4 EX-32.1 a20240503-q110qex321.htm EX-32.1 8107
5 EX-10.1 a20240503-q110qex101.htm EX-10.1 36674
  Complete submission text file 0001628280-24-020299.txt   5601899

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vir-20240331.xsd EX-101.SCH 44878
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vir-20240331_cal.xml EX-101.CAL 66354
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vir-20240331_def.xml EX-101.DEF 195049
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vir-20240331_lab.xml EX-101.LAB 545807
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vir-20240331_pre.xml EX-101.PRE 372118
72 EXTRACTED XBRL INSTANCE DOCUMENT vir-20240331_htm.xml XML 550291
Mailing Address 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158
Business Address 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Filer) CIK: 0001706431 (see all company filings)

IRS No.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39083 | Film No.: 24913332
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)